PLEASANTON, Calif., Feb. 15, 2024 /PRNewswire/ — 10x Genomics, Inc. ( Nasdaq: TXG ), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided outlook for 2024.